HIV transcription is induced by the HIV-1 Tat protein, in concert with cellular co-factors including CDK9, CDK2, NF-κB, and others. The cells of most of the body\u27s organs are exposed to ∼3-6% oxygen, but most in vitro studies of HIV replication are conducted at 21% oxygen. We hypothesized that activities of host cell factors involved in HIV-1 replication may differ at 3% versus 21% O2, and that such differences may affect HIV-1 replication. Here we show that Tat-induced HIV-1 transcription was reduced at 3% O2 compared to 21% O2. HIV-1 replication was also reduced in acutely or chronically infected cells cultured at 3% O2 compared to 21% O2. This reduction was not due the decreased cell growth or increased cellular toxicity and also not ...
Various biological processes, such as photosensitization or inflammatory reactions, can generate sin...
The emergence of drug-resistant HIV-1 strains presents a challenge for the design of new drugs. Targ...
The emergence of drug-resistant HIV-1 strains presents a challenge for the design of new therapy. Ta...
Abstract: Viral replication is defined by the cellular microenvironment and one key factor is local ...
Viral replication is defined by the cellular microenvironment and one key factor is local oxygen ten...
Background: Transcription of HIV-1 genes is activated by HIV-1 Tat protein, which induces phosphoryl...
Background: HIV-1 transcription is activated by the viral Tat protein that recruits host positive tr...
Despite efficient antiretroviral therapy, eradication of HIV-1 infection is challenging and requires...
OBJECTIVES: A common denominator shared by several HIV-1 reactivation agents such as certain cytokin...
Background: HIV-1 Tat protein recruits human positive transcription elongation factor P-TEFb, consis...
The human positive transcription elongation factor P-TEFb is composed of two subunits, cyclin T1 (hC...
The human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2), which cause acquired immune defici...
Background: Heme oxygenase-1 (HO-1) is a protein secreted by immune cells as a part of immune respon...
Background: Heme oxygenase-1 (HO-1) is a protein secreted by immune cells as a part of immune respon...
We previously reported that cell cycle-dependent kinase 2 (CDK2) is required for human immunodeficie...
Various biological processes, such as photosensitization or inflammatory reactions, can generate sin...
The emergence of drug-resistant HIV-1 strains presents a challenge for the design of new drugs. Targ...
The emergence of drug-resistant HIV-1 strains presents a challenge for the design of new therapy. Ta...
Abstract: Viral replication is defined by the cellular microenvironment and one key factor is local ...
Viral replication is defined by the cellular microenvironment and one key factor is local oxygen ten...
Background: Transcription of HIV-1 genes is activated by HIV-1 Tat protein, which induces phosphoryl...
Background: HIV-1 transcription is activated by the viral Tat protein that recruits host positive tr...
Despite efficient antiretroviral therapy, eradication of HIV-1 infection is challenging and requires...
OBJECTIVES: A common denominator shared by several HIV-1 reactivation agents such as certain cytokin...
Background: HIV-1 Tat protein recruits human positive transcription elongation factor P-TEFb, consis...
The human positive transcription elongation factor P-TEFb is composed of two subunits, cyclin T1 (hC...
The human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2), which cause acquired immune defici...
Background: Heme oxygenase-1 (HO-1) is a protein secreted by immune cells as a part of immune respon...
Background: Heme oxygenase-1 (HO-1) is a protein secreted by immune cells as a part of immune respon...
We previously reported that cell cycle-dependent kinase 2 (CDK2) is required for human immunodeficie...
Various biological processes, such as photosensitization or inflammatory reactions, can generate sin...
The emergence of drug-resistant HIV-1 strains presents a challenge for the design of new drugs. Targ...
The emergence of drug-resistant HIV-1 strains presents a challenge for the design of new therapy. Ta...